Fonkozomib 3.5mg
Fonkozomib 3.5mg Injection A proteasome inhibitor containing Bortezomib for multiple myeloma and mantle cell lymphoma treatment. Used in newly diagnosed patients or those whose disease has returned after previous therapy.
Fonkozomib 3.5mg
Product Name: Fonkozomib 3.5mg Injection
Generic Name: Bortezomib
Indications
- Multiple Myeloma: for treatment of adult patients with previously untreated multiple myeloma, or for adult patients with relapsed or refractory multiple myeloma who have received at least one prior therapy.
- Mantle Cell Lymphoma: for treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy.
Strength: 3.5 mg per vial
Pack Size: Single-use vial
Dosage Form: Lyophilized powder for solution for injection
Categories: Pharmaceuticals
Therapeutic Class: Antineoplastic Agent (Proteasome Inhibitor)